Related Experiment Video
Updated: Jun 6, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
[Diabetic retinopathy, practical value of classification]
Vitalie Cuşnir1, Valeriu Cuşnir, Eugen Bendelic
1Catedra Oftalmologie USMF "Nicolae Testemiţanu".
The Aim:
In this work will be exposed the modern classification of diabetic retinopathy (DR). The aim is to familiarize ophthalmologist, endocrinologist and therapeutic doctors with the newest and unique tendency of diagnosis of this pathology.
Materials And Methods:
It was effectuated a special literature (recent edited, post 2000) study. The DR classification evolution was studied and the last and to the most common accepted classification the attention was attracted.
Results And Discussions:
The unique in our days validated classification is ETDRS (Early Treatment Diabetic Retinopathy Study). One of recent appeared classifications is ALFEDIAM (Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques) in 1996, derived and simplified from ETDRS classification, in this moment is utilized in France. Non proliferative diabetic retinopathy (NPDR) can be mild, moderate or severe. Proliferative diabetic retinopathy can be early, moderate, severe, complicated. Maculopathy classification by Brescnic adopted in 1983 include focal macular edema, diffuse macular edema, ischemic maculopathy.
Conclusions:
ALFEDIAM classification, derived and simplified from the unique international validated classification of DR on our days ETDRS is accessible to all ophthalmologists, and their collaboration with endocrinologist and therapist doctors. The use of ALFEDIAM classification give the possibility of interaction of effectuated work with the materials of international literature.
Related Concept Videos
Diabetic Retinopathy
Diabetic Nephropathy
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Complications of Diabetes Mellitus
Diabetes: Symptoms, Diagnosis, and Complications
Type I Diabetes III: Clinical Manifestations
